Inhibitors and knock-down strategies showed that the JAK/STAT3 pathway regulates CPT1 and FAO, and thereby self-renewal in breast cancer CD44+/CD24− mammosphere TICs [48]. This evidence concerns the gene CD44 and breast cancer.